Table 2.
Fibrosis stage | Cut-off value (kPa) | AUROC | Se | Sp | PPV | NPV | References |
---|---|---|---|---|---|---|---|
Stage ≥ 2 | 6.65 | 0.865 | 0.88 | 0.74 | 0.79 | 0.85 | Yoneda M et al. Dig Liver Dis. 2008 [61] |
Stage ≥ 3 | 9.8 | 0.904 | 0.85 | 0.81 | 0.64 | 0.93 | |
Stage = 4 | 17.0 | 0.991 | 1.00 | 0.97 | 0.75 | 1.00 | |
Stage ≥ 2 | 7.4 | 0.99 | 1 | 0.92 | 0.8 | 1 | Nobili V et al. Hepatology. 2008 [65] |
Stage ≥ 3 | 10.2 | 1.00 | 1.00 | 1.00 | 1.00 | ND | |
Stage ≥ 2 | 7 | 0.84 | 0.79 | 0.76 | 0.7 | 0.84 | Wong VW et al. Hepatology. 2010 [66] |
Stage ≥ 3 | 8.7 | 0.93 | 0.84 | 0.83 | 0.6 | 0.95 | |
Stage = 4 | 10.3 | 0.95 | 0.92 | 0.88 | 0.46 | 0.99 | |
Stage ≥ 2 | 6.8 | 0.79 | 0.67 | 0.84 | 0.6 | 0.88 | Lupsor M, et al. J Gastrointestin Liver Dis. 2010 [67] |
Stage ≥ 3 | 10.4 | 0.98 | 1 | 0.97 | 0.71 | 1 | |
Stage ≥ 2 | 7.25 | 0.795 | 0.69 | 0.7 | ND | ND | Petta S et al. Aliment Pharmacol Ther. 2011 [58] |
Stage ≥ 3 | 8.75 | 0.87 | 0.76 | 0.78 | ND | ND | |
Stage ≥ 2 | 7 | ND | 0.76 | ND | ND | ND | Gaia S, et al. J Hepatol. 2011 [68] |
Stage ≥ 3 | 8 | ND | 0.65 | ND | ND | ND | |
Stage = 4 | 10.5 | ND | 0.78 | ND | ND | ND | |
Stage > 2 | 7.0 (6.2) | 0.83 (0.80) | 0.79 (0.73) | 0.64 (0.66) | 0.62 (0.54) | 0.80 (0.75) | Wong VW et al. Am J Gastroenterol. 2012 [59] |
Stage ≥ 3 | 8.7 (7.2) | 0.87 (0.85) | 0.83 (0.78) | 0.84 (0.78) | 0.58 (0.60) | 0.93 (0.89) | |
Stage = 4 | 10.3 (7.9) | 0.89 (0.91) | 0.81 (0.88) | 0.83 (0.76) | 0.35 (0.35) | 0.98 (0.98) | |
Stage > 2 | 7.6 | 0.81 | 73 | 78 | 48 | 91 | Naveau S et al. Obes Surg. 2014 [59] |
Stage = 3 | 7.6 | 0.85 | 100 | 74 | 27 | 100 | |
Stage > 2 | 9.8 (6.2) | 0.82 | 0.6 (0.9) | 0.9 (0.45) | ND | ND | Cassinotto C et al. Hepatology 2016 [64] |
Stage ≥ 3 | 12.5 (8.2) | 0.86 | 0.57 (0.9) | 0.9 (0.61) | ND | ND | |
Stage = 4 | 16.1 (9.5) | 0.87 | 0.65 (0.92) | 0.9 (0.62) | ND | ND | |
Stage > 2 | 11 | 0.82 | 0.65 | 0.89 | 0.88 | 0.66 | Imajo K et al. Gastroenterology. 2016 [62] |
Stage ≥ 3 | 11.4 | 0.88 | 0.86 | 0.84 | 0.75 | 0.92 | |
Stage = 4 | 14 | 0.92 | 1 | 0.76 | 0.73 | 1 | |
Stage > 2 | 6.9 | 0.86 | 0.79 | 0.82 | 0.66 | 0.9 | Park CC et al. Gastroenterology. 2017 [63] |
Stage ≥ 3 | 7.3 | 0.8 | 0.78 | 0.78 | 0.45 | 0.94 | |
Stage = 4 | 6.9 | 0.69 | 0.63 | 0.66 | 0.15 | 0.95 | |
Stage > 2 | 7.8 | 0.83 | 0.82 | 0.78 | 0.68 | 0.88 | Chen J et al. Radiology 2017 [70] |
Stage ≥ 3 | 7.6 | 0.84 | 0.84 | 0.64 | 0.43 | 0.92 | |
Stage = 4 | 14.6 | 0.9 | 0.82 | 0.92 | 0.64 | 0.97 |
AUROC Area under the receiver-operating characteristic, NPV negative predictive value, PPV positive predictive value, Se sensitivity, Sp specificity